ifosfamide has been researched along with Chronic Kidney Diseases in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nephrotoxicity is a known side effect of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate (GFR) impairment, proteinuria, tubulopathy, and hypertension." | 5.01 | Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer. ( Bökenkamp, A; Kooijmans, EC; Tettero, JM; Tjahjadi, NS; van der Pal, HJ; van Dulmen-den Broeder, E; Veening, MA, 2019) |
| " Nephrotoxicity is one of these known (acute) side effects of several treatments, including cisplatin, carboplatin, ifosfamide, radiotherapy and nephrectomy, and can cause glomerular filtration rate impairment, proteinuria, tubulopathy and hypertension." | 4.89 | Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. ( Blufpand, H; Bökenkamp, A; Jaspers, MW; Knijnenburg, SL; Kremer, LC; Mulder, RL; Schouten-Van Meeteren, AY; van Dulmen-den Broeder, E; Veening, MA, 2013) |
| "In addition, polyploidy of TEC was observed to correlate with loss of lysozyme staining." | 1.91 | Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy. ( Broekhuizen, R; Goldschmeding, R; Haveman, LM; Janssens, GO; Keijzer-Veen, MG; Knoppert, SN; Lilien, MR; Nguyen, TQ; Stokman, MF; Valentijn, FA; van den Berg, G; van den Heuvel-Eibrink, MM; van Kempen, S, 2023) |
| "Childhood cancer survivors treated with cisplatin, ifosfamide, or carboplatin are at risk for late kidney and blood pressure (BP) abnormalities." | 1.48 | Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study. ( Harel-Sterling, M; Hessey, E; Huynh, L; McMahon, KR; Pizzi, M; Zappitelli, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Knoppert, SN | 1 |
| Keijzer-Veen, MG | 1 |
| Valentijn, FA | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Lilien, MR | 1 |
| van den Berg, G | 1 |
| Haveman, LM | 1 |
| Stokman, MF | 1 |
| Janssens, GO | 1 |
| van Kempen, S | 1 |
| Broekhuizen, R | 1 |
| Goldschmeding, R | 1 |
| Nguyen, TQ | 1 |
| Paul, A | 1 |
| Duncan, A | 1 |
| Bacchetta, J | 1 |
| Dubourg, L | 1 |
| Marec-Bérard, P | 1 |
| Tanné, C | 1 |
| McMahon, KR | 1 |
| Harel-Sterling, M | 1 |
| Pizzi, M | 1 |
| Huynh, L | 1 |
| Hessey, E | 1 |
| Zappitelli, M | 1 |
| Kooijmans, EC | 1 |
| Bökenkamp, A | 2 |
| Tjahjadi, NS | 1 |
| Tettero, JM | 1 |
| van Dulmen-den Broeder, E | 2 |
| van der Pal, HJ | 1 |
| Veening, MA | 2 |
| Knijnenburg, SL | 1 |
| Mulder, RL | 1 |
| Schouten-Van Meeteren, AY | 1 |
| Blufpand, H | 1 |
| Kremer, LC | 1 |
| Jaspers, MW | 1 |
| Zubowska, M | 1 |
| Wyka, K | 1 |
| Fendler, W | 1 |
| Młynarski, W | 1 |
| Zalewska-Szewczyk, B | 1 |
| Jaśkowski, P | 1 |
| Krzanowska, K | 1 |
| Miarka, P | 1 |
| Krzanowski, M | 1 |
| Sułowicz, W | 1 |
| Kesik, V | 1 |
| Demirkaya, E | 1 |
| Buyukpamukçu, M | 1 |
| Perazella, MA | 1 |
| Moeckel, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia in Pediatric Oncology Patients Treated With Cisplatin-Based Chemotherapy: Randomized Clinical Trial[NCT03449693] | Phase 2 | 214 participants (Anticipated) | Interventional | 2017-10-19 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ifosfamide and Chronic Kidney Diseases
| Article | Year |
|---|---|
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2019 |
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Child; Cisplatin; Glomerular Filtration Rate; Humans; Hyp | 2013 |
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Diphosphonates; Humans; Ifosfamide; Kidney Gl | 2010 |
6 other studies available for ifosfamide and Chronic Kidney Diseases
| Article | Year |
|---|---|
Cellular senescence in kidney biopsies is associated with tubular dysfunction and predicts CKD progression in childhood cancer patients with karyomegalic interstitial nephropathy.
Topics: Biopsy; Cellular Senescence; Child; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Kidney; | 2023 |
Chronic kidney disease consecutive to chemotherapy for chondroblastic osteosarcoma: A report on 6 pediatric cases.
Topics: Adolescent; Bone Neoplasms; Child; Humans; Ifosfamide; Osteosarcoma; Renal Insufficiency, Chronic; R | 2021 |
Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
Topics: Acute Kidney Injury; Antineoplastic Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C | 2018 |
Interleukin 18 as a marker of chronic nephropathy in children after anticancer treatment.
Topics: Adolescent; Antineoplastic Agents; beta 2-Microglobulin; Biomarkers; Carboplatin; Child; Child, Pres | 2013 |
[Patient receiving peritoneal dialysis after treatment of ovarian cancer].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; If | 2014 |
Urinary neutrophil gelatinase associated lipocalin as a biomarker in ifosfamide induced chronic renal failure.
Topics: Acute-Phase Proteins; Adolescent; Antineoplastic Agents, Alkylating; Biomarkers; Case-Control Studie | 2015 |